Albert Seymour
Chief Executive Officer at Seamless Therapeutics
Net worth: 236 708 $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Kush Parmar | M | 42 |
Ensoma, Inc.
 Ensoma, Inc. Miscellaneous Commercial ServicesCommercial Services Ensoma, Inc. believes in the future of medicine and is committed to creating a new therapeutic category to tackle diseases that affect millions around the world, such as cancer and autoimmune disease, as well as inherited conditions. Ensoma is based in Boston, MA and has subsidiaries in Denmark. The company's engenious™ platform combines innovative delivery technology with the full DNA editing toolkit to address these disorders. Ensoma is supported by top-tier investors, a strategic collaboration with Takeda, and a passionate team. The company was founded by André Lieber, Hans-Peter Kiem, Kush M. Parmar, and the CEO is Emile F. Nuwaysir. | 8 years |
| Min Wang | M | - |
Ensoma, Inc.
Ensoma, Inc. Miscellaneous Commercial ServicesCommercial Services Ensoma, Inc. believes in the future of medicine and is committed to creating a new therapeutic category to tackle diseases that affect millions around the world, such as cancer and autoimmune disease, as well as inherited conditions. Ensoma is based in Boston, MA and has subsidiaries in Denmark. The company's engenious™ platform combines innovative delivery technology with the full DNA editing toolkit to address these disorders. Ensoma is supported by top-tier investors, a strategic collaboration with Takeda, and a passionate team. The company was founded by André Lieber, Hans-Peter Kiem, Kush M. Parmar, and the CEO is Emile F. Nuwaysir. | - |
| Paul A. Bottomley | M | 70 |
The Johns Hopkins University
| 30 years |
| Mark Chin | M | 42 |
Ensoma, Inc.
Ensoma, Inc. Miscellaneous Commercial ServicesCommercial Services Ensoma, Inc. believes in the future of medicine and is committed to creating a new therapeutic category to tackle diseases that affect millions around the world, such as cancer and autoimmune disease, as well as inherited conditions. Ensoma is based in Boston, MA and has subsidiaries in Denmark. The company's engenious™ platform combines innovative delivery technology with the full DNA editing toolkit to address these disorders. Ensoma is supported by top-tier investors, a strategic collaboration with Takeda, and a passionate team. The company was founded by André Lieber, Hans-Peter Kiem, Kush M. Parmar, and the CEO is Emile F. Nuwaysir. | - |
| Paula Soteropoulos | F | 56 |
Ensoma, Inc.
Ensoma, Inc. Miscellaneous Commercial ServicesCommercial Services Ensoma, Inc. believes in the future of medicine and is committed to creating a new therapeutic category to tackle diseases that affect millions around the world, such as cancer and autoimmune disease, as well as inherited conditions. Ensoma is based in Boston, MA and has subsidiaries in Denmark. The company's engenious™ platform combines innovative delivery technology with the full DNA editing toolkit to address these disorders. Ensoma is supported by top-tier investors, a strategic collaboration with Takeda, and a passionate team. The company was founded by André Lieber, Hans-Peter Kiem, Kush M. Parmar, and the CEO is Emile F. Nuwaysir. | 4 years |
| Kenneth J. Pienta | M | 64 |
The Johns Hopkins University
| 30 years |
| Mario Eisenberger | M | 74 |
The Johns Hopkins University
| 31 years |
| Kouki Harasaki | M | - |
Ensoma, Inc.
Ensoma, Inc. Miscellaneous Commercial ServicesCommercial Services Ensoma, Inc. believes in the future of medicine and is committed to creating a new therapeutic category to tackle diseases that affect millions around the world, such as cancer and autoimmune disease, as well as inherited conditions. Ensoma is based in Boston, MA and has subsidiaries in Denmark. The company's engenious™ platform combines innovative delivery technology with the full DNA editing toolkit to address these disorders. Ensoma is supported by top-tier investors, a strategic collaboration with Takeda, and a passionate team. The company was founded by André Lieber, Hans-Peter Kiem, Kush M. Parmar, and the CEO is Emile F. Nuwaysir. | - |
| Nihal Sinha | M | - |
Ensoma, Inc.
Ensoma, Inc. Miscellaneous Commercial ServicesCommercial Services Ensoma, Inc. believes in the future of medicine and is committed to creating a new therapeutic category to tackle diseases that affect millions around the world, such as cancer and autoimmune disease, as well as inherited conditions. Ensoma is based in Boston, MA and has subsidiaries in Denmark. The company's engenious™ platform combines innovative delivery technology with the full DNA editing toolkit to address these disorders. Ensoma is supported by top-tier investors, a strategic collaboration with Takeda, and a passionate team. The company was founded by André Lieber, Hans-Peter Kiem, Kush M. Parmar, and the CEO is Emile F. Nuwaysir. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Paul Alloway | M | 53 | - | |
| Arthur Tzianabos | M | 60 | - | |
| W. Smith | M | 68 | 6 years | |
| Charles Michaud | M | 57 | - | |
| Mahendra Shah | M | 79 | 2 years | |
| Dennis G. Prado | M | - |
University of Pittsburgh
| 2 years |
| Cameron Wheeler | M | 45 | 2 years | |
| Bryan D. Jarman | M | - |
The Johns Hopkins University
| 5 years |
| George A. Jurgensen | M | - |
University of Delaware
| 5 years |
| Robert Harrell | M | - |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | 8 years |
| Jeffrey Poulton | M | 56 | - | |
| Thomas Luby | M | - |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | 3 years |
| Suzanne M. Hay | F | 52 |
University of Delaware
| 5 years |
| Timothy Kelly | M | 55 | 5 years | |
| Mark Gorman | M | - |
University of Pittsburgh
| 3 years |
| Alise Reicin | M | 63 | - | |
| Siyamak Rasty | M | 60 |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | 8 years |
| Ryan Walsh | M | - |
University of Pittsburgh
| 5 years |
| Nilesh Javerchand Jain | M | - |
University of Pittsburgh
| 1 years |
| Howard Mayer | M | 61 |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | 6 years |
| Michele Mueser | F | - |
University of Pittsburgh
| 8 years |
| Mary Thistle | F | 64 | - | |
| Sean Clark | M | 55 |
University of Delaware
| 4 years |
| Matt Patterson | M | 52 | - | |
| Erin Jones | M | 52 |
University of Pittsburgh
| 4 years |
| Chris J. Perriello | M | - |
University of Pittsburgh
| 4 years |
| Sara M. Dillon | F | - |
University of Pittsburgh
| 4 years |
| Carrie Ann Zayas Quintana | F | - |
University of Pittsburgh
| 4 years |
| Philip Cheng | M | - |
The Johns Hopkins University
| 4 years |
| Tammy Sue Neff | F | - |
University of Pittsburgh
| 2 years |
| Jill Penrose | F | 51 |
University of Pittsburgh
| 4 years |
| James M. Giammarco | M | - |
University of Pittsburgh
| 2 years |
| Umut Ergun | M | - |
University of Pittsburgh
| 3 years |
| Michael P. Sullivan | M | - |
University of Pittsburgh
| 4 years |
| Eric Kazatsky | M | - |
University of Pittsburgh
| 4 years |
| Ling Li | M | 62 |
University of Pittsburgh
| 3 years |
| Ory Okolloh | F | 47 |
University of Pittsburgh
| 4 years |
| Kang Lin Huang | M | - |
University of Pittsburgh
| 3 years |
| Handy Purnomo Soetedjo | M | - |
University of Pittsburgh
| 2 years |
| Yvana L. Rizzo | F | - |
University of Pittsburgh
| 4 years |
| Lauren Rabinovic | M | - |
University of Pittsburgh
| 6 years |
| Jae-Woo Jung | M | 56 |
University of Pittsburgh
| 1 years |
| Tom Curran | M | - |
University of Pittsburgh
| 4 years |
| Richard Beaty | M | - |
University of Pittsburgh
| 4 years |
| Maha Eltobgy | F | 53 |
The Johns Hopkins University
| 2 years |
| Delphine Traoré Maïdou | F | - |
University of Pittsburgh
| 4 years |
| William Matthew Yurkovich | M | - |
University of Pittsburgh
| 5 years |
| Anne Palmerine | F | - |
University of Pittsburgh
| 2 years |
| Ling Li | M | 63 |
University of Pittsburgh
| 3 years |
| Brian James Lazorishak | M | - |
University of Pittsburgh
| 4 years |
| Ahmet Turgut Tokgöz | M | - |
The Johns Hopkins University
| 1 years |
| Terri L. Svidro | F | 64 |
University of Pittsburgh
| - |
| Michael J. Capizzi | M | - |
University of Pittsburgh
| 8 years |
| Chuck Crow | M | - |
The Johns Hopkins University
| 10 years |
| Kunal Jerath | M | - |
The Johns Hopkins University
| 4 years |
| Chang Lee | M | - |
The Johns Hopkins University
| 4 years |
| Wanlin Xia | M | - |
University of Pittsburgh
| 3 years |
| Dana Larson | M | - |
University of Pittsburgh
| 5 years |
| Tadamichi Nagashima | M | - |
University of Pittsburgh
| 3 years |
| Scott L. Olson | M | - |
University of Pittsburgh
| 3 years |
| Bill A. Avoli | M | - |
University of Pittsburgh
| 2 years |
| Pamela Samuelson | F | - |
University of Pittsburgh
| 15 years |
| Ted W. Bair | M | - |
University of Pittsburgh
| 3 years |
| Joanna Lynne Bewick | F | - |
University of Pittsburgh
| 2 years |
| Debbie F. Graver | F | - |
University of Pittsburgh
| 3 years |
| Andreas Beck | M | - |
University of Pittsburgh
| 4 years |
| Robert K. Casey | M | - |
University of Pittsburgh
| 3 years |
| Matthew B. Perkins | M | 57 |
University of Pittsburgh
| 2 years |
| Matthew Eric Peterson | M | 56 |
University of Pittsburgh
| 4 years |
| Joseph R. Tiano | M | - |
University of Pittsburgh
| 3 years |
| David Duke | M | - |
University of Pittsburgh
| 1 years |
| Karen Schiff Joseph | F | - |
University of Pittsburgh
| 4 years |
| Yoshitomo Hamuro | M | - |
University of Pittsburgh
| 3 years |
| Steve J. McGreevy | M | - |
University of Pittsburgh
| 1 years |
| Arthur A. Boni | M | - |
University of Pittsburgh
| - |
| Edward Kisak | M | - |
University of Pittsburgh
| 4 years |
| Antoine Del Serra | M | - |
University of Pittsburgh
| 1 years |
| Ryan Fischer | M | - |
University of Pittsburgh
| 4 years |
| Derek Keith Ralph | M | - |
University of Pittsburgh
| 4 years |
| Jeffrey Hibbs | M | - |
University of Pittsburgh
| 4 years |
| H. Jude | M | - |
University of Pittsburgh
| 4 years |
| Oscar Bronsther | M | 71 |
University of Pittsburgh
| 5 years |
| Lei Li | M | - |
University of Pittsburgh
| 3 years |
| Henry Shaw Beukema | M | - |
University of Pittsburgh
| 2 years |
| Chris Pacitti | M | 54 |
The Johns Hopkins University
| 4 years |
| Jon Koteski | M | - |
University of Pittsburgh
| 2 years |
| Pamela Peele | M | - |
University of Pittsburgh
| 11 years |
| Rebecca Pavese | F | - |
University of Pittsburgh
| 4 years |
| Patrick Broderick | M | - |
University of Pittsburgh
| 4 years |
| Vincent R. Barbera | M | - |
University of Pittsburgh
| 4 years |
| Brian Allen Inman | M | - |
University of Pittsburgh
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Albert Seymour
- Personal Network
